Form 4: Amneal Pharmaceuticals Director Deborah M. Autor Reports Stock Unit Vesting
SEC Form 4
Director Deborah M. Autor reports vesting of restricted stock units into Class A Common Stock of Amneal Pharmaceuticals.
Summary
- On May 10, 2024, Deborah M. Autor, a director of Amneal Pharmaceuticals, reported the vesting of 76,453 restricted stock units, which converted into Class A Common Stock.
- Following this transaction, Autor directly owns 131,402 shares of Class A Common Stock.
- The restricted stock units were granted on May 9, 2023, and vested on May 10, 2024.
Sentiment
Score: 6
Explanation: The sentiment is neutral as it reports a standard vesting event. It's neither particularly positive nor negative.
Positives
- The vesting of restricted stock units indicates a continued alignment of the director's interests with the company's performance.
Industry Context
Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.
Stakeholder Impact
- The vesting of stock units can have a minor positive impact on shareholder confidence as it aligns management's interests with shareholders.
Key Dates
| Date | Description |
|---|---|
| 05/09/2023 | Reporting person was granted 76,453 restricted stock units |
| 05/10/2024 | Restricted stock units vested |
| 05/14/2024 | Date of signature for the report |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.